Concepedia

Robert Rehfuss

RR

Statistics

Publications

26

Citations

1.3K

H-Index

19

Active since

1987

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Syracuse University

Vollum Institute

McGill University

Robert Rehfuss is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, life sciences, and medicinal chemistry.

Publications per year

1987–2014

26

Publications

26

The cAMP-regulated enhancer-binding protein ATF-1 activates transcription in response to cAMP-dependent protein kinase A.

Robert Rehfuss, Kevin M. Walton, Marc Loriaux et al. · Journal of Biological Chemistry · 1991 · 227 citations · Full text

, , +16

A dominant repressor of cyclic adenosine 3',5'-monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo.

Kevin M. Walton, Robert Rehfuss, John C. Chrivia et al. · Molecular Endocrinology · 1992 · 206 citations · Full text

, , +17

Esperamicins, a class of potent antitumor antibiotics: mechanism of action.

B H Long, Jerzy Golik, Salvatore Forenza et al. · Proceedings of the National Academy of Sciences · 1989 · 120 citations · Full text

, , +15

Engineering of a Novel Anti-CD40L Domain Antibody for Treatment of Autoimmune Diseases

Jenny Xie, Aaron P. Yamniuk, Virna Borowski et al. · The Journal of Immunology · 2014 · 70 citations

, , +12

Conformationally Constrained <i>ortho-</i>Anilino Diaryl Ureas: Discovery of 1-(2-(1′-Neopentylspiro[indoline-3,4′-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a Potent, Selective, and Bioavailable P2Y<sub>1</sub> Antagonist

Jennifer X. Qiao, Tammy C. Wang, Réjean Ruel et al. · Journal of Medicinal Chemistry · 2013 · 70 citations · Full text

, , +17

1–5 of 26